EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in nonsmall cell lung cancer cells. Gao L, Yang T, Zhang S, Liang Y, et al. Oncol Rep 2021;45.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gao L, Yang T, Zhang S, Liang Y, et al. EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in nonsmall cell lung cancer cells. Oncol Rep 2021;45.
PMID: 33907840